E
NVRO

Ergoteles’s NEVRO CORP. NVRO Stock Holding History

Ergoteles’s Portfolio NVRO Stock Details NVRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-48,873
Closed -$2.28M – 1970
2022
Q3 		$2.28M Buy
48,873
+40,491
+483% +$1.88M 0.08% 247
2022
Q2 		$367K Sell
8,382
-9,827
-54% -$540K 0.01% 997
2022
Q1 		$1.32M Buy
18,209
+12,165
+201% +$877K 0.05% 355
2021
Q4 		$490K Sell
6,044
-12,936
-68% -$1.3M 0.02% 647
2021
Q3 		$2.21M Buy
18,980
+9,773
+106% +$1.28M 0.08% 249
2021
Q2 		$1.53M Buy
9,207
+6,807
+284% +$1.06M 0.04% 407
2021
Q1 		$335K Buy
+2,400
New +$392K 0.01% 549
2020
Q4 		– Sell
-2,200
Closed -$306K – 952
2020
Q3 		$306K Buy
+2,200
New +$294K 0.04% 334

Other funds holding NVRO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ergoteles's NVRO Position: Q4 2022 in Review

Ergoteles sold out of NEVRO CORP. (NVRO) in Q4 2022, closing a stake of 48,873 shares — an estimated $2.28M sold.

Ergoteles first reported a position in NVRO in Q3 2020 and held it in 8 quarters. The position peaked at $2.28M in Q3 2022. 169 funds tracked by Wall St. Rank hold NVRO as of Q4 2022.

  • Ergoteles reported no remaining NEVRO CORP. position as of Q4 2022 after selling out during the quarter.
  • Ergoteles sold 48,873 NEVRO CORP. shares in Q4 2022, an estimated $2.28M.
  • Ergoteles first reported a position in NEVRO CORP. in Q3 2020 and held it in 8 quarters.
  • Ergoteles's NEVRO CORP. position peaked at $2.28M in Q3 2022.
  • 169 funds tracked by Wall St. Rank held NEVRO CORP. as of Q4 2022.

Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.